Latest News & Features
Big Pharma
MSD, known as Merck in the US and Canada, has won against a case concerning branded diabetes treatment Janumet XR at the US Court of Appeals for the Federal Circuit. 29 September 2022
Biotechnology
New partner specialises in chemical-related tech | USPTO-registered litigator is also certified licensing professional | Appointment follows several hires in firm’s patents department. 29 September 2022
Big Pharma
Bid to stay invalidity decision pending a SCOTUS appeal fails | Patent covers a multiple sclerosis drug | Company could take $300m hit if generics are launched. 29 September 2022
Biotechnology
The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech. 27 September 2022
Americas
Pharma firm beats back digital health company over migraine tracking app / Indiana’s Uniform Trade Secrets Act cited by US judge. 27 September 2022
article
Law firm Finnegan has announced that partner Scott Burwell has been appointed as the firm’s partner-in-charge of diversity, equity, and inclusion. 27 September 2022
article
IP law firm Powell Gilbert has expanded its life sciences team with the appointment of James Bergus. 22 September 2022
Biotechnology
Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out. 22 September 2022
Americas
Federal Circuit denies petition to rehear dispute over multiple sclerosis medicine | Company will petition highest court over invalidity ruling. 22 September 2022
Big Pharma
Pfizer’s ‘Breakthrough’ programme is aimed at Black, Latino and Native Americans | A healthcare membership organisation filed the complaint. 20 September 2022